Industry News

      Zymergen to Purchase, an AI-Powered Clinical Trial Design Firm

      Zymergen, a leading provider of artificial intelligence (AI) and machine learning (ML) solutions, has recently announced the acquisition of, an AI-powered clinical trial...

      Exscientia and Bristol Myers Squibb Launch First Human Clinical Trial of EXS4318, a PKC Theta Inhibitor.

      Exscientia, a leading artificial intelligence (AI) drug discovery company, and Bristol Myers Squibb (BMS), a global biopharmaceutical company, have announced the launch of the...

      Recent Articles

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.